Table 2. Mean PSA (ng/mL), the PSA Range as Well as the Histological Types.
| Study | PSA (ng/mL) |
Histological type |
||
|---|---|---|---|---|
| Mean PSA (ng/mL) | PSA range (ng/mL) | Adenocarcinoma | Others | |
| Niang et al [8] | 1,447.57 | 5.88 - 21,660 | Commonest | |
| Amegbor et al [12] | 88.5 | 7.8 - 560.4 | 95% | 1.9% squamous cell |
| Ndoye et al [13] | 1,447.57 ± 812 | 5.88 - 21.660 | 97.7 % | |
| Tengue et al [14] | 123.5 | 100% | ||
| Anunobi [15] | < 4.1 - > 100 | 99.1% | ||
| Kyei et al [10] | 16.12 ± 13.68 | 2.45 - 62.20 | ||
| Kabore [16] | 483.3 ± 145.4 | 1 - 7,421 | 100% | |
| Kabore et al [18] | 537 | 8.4 - 17,850 | 100% | |
| Gueye et al [19] | 72.2 | 6 - 578.9 | ||
| Obiorah et al [20] | 100% | |||
| Babacar et al [21] | 25 | 6 - 80 | 100% | |
| Badmus et al [22] | 98.4% | Adenosquamous | ||
| Mawakyoma [23] | 2.6 - > 20 | 99.1% | Embryonal rhabdomyosarcoma | |
PSA: prostate specific antigen.